Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | 544.00 Mn |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | 255.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | 106.00 Mn |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | 66.03 Mn |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | 148.70 Mn |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | 720.78 Mn |
| 10 | Amylyx Pharmaceuticals | 3.70 Bn | 3.70 Bn | - | 111.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111.20 Mn |
| Mar 31, 2026 | 110.56 Mn |
| Dec 31, 2025 | 94.57 Mn |
| Sep 30, 2025 | 93.33 Mn |
| Jun 30, 2025 | 89.14 Mn |
| Mar 31, 2025 | 85.70 Mn |
| Dec 31, 2024 | 68.14 Mn |
| Sep 30, 2024 | 68.09 Mn |
| Jun 30, 2024 | 68.02 Mn |
| Mar 31, 2024 | 67.85 Mn |
| Dec 31, 2023 | 69.99 Mn |
| Sep 30, 2023 | 69.75 Mn |
| Jun 30, 2023 | 70.13 Mn |
| Mar 31, 2023 | 70.86 Mn |
| Dec 31, 2022 | 58.50 Mn |
| Sep 30, 2022 | 58.53 Mn |
| Jun 30, 2022 | 58.28 Mn |
| Mar 31, 2022 | 51.60 Mn |
| Dec 31, 2021 | 6.59 Mn |
| Sep 30, 2021 | 6.76 Mn |